Erratum: Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial (Lancet (2014) 384 (1349-1357))

The Lancet

Volumn 384, Issue 9951, 2014, Pages 1348-

  Dungan, K M ^a   Povedano, S T ^a   Forst, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 84908149256     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61817-1     Document Type: Erratum

References (0)